
Efficacy and optimal dosing interval of the long-acting beta2 agonist, vilanterol, in persistent asthma: A randomised trial
Richard Sterling, Jessica Lim, Lucy Frith, Neil G. Snowise, Loretta Jacques, Brett HaumannVolume:
106
Année:
2012
Langue:
english
DOI:
10.1016/j.rmed.2012.03.007
Fichier:
PDF, 374 KB
english, 2012